ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OKYO Okyo Pharma Limited

91.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Okyo Pharma Limited LSE:OKYO London Ordinary Share GG00BD3FV870 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 91.00 1.20 1.60 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

West African Minerals Corporation Change of Name and Corporate Update (8050D)

02/02/2018 1:17pm

UK Regulatory


Okyo Pharma (LSE:OKYO)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Okyo Pharma Charts.

TIDMWAFM

RNS Number : 8050D

West African Minerals Corporation

02 February 2018

2 February 2018

For immediate release

West African Minerals Corporation

("WAFM" or the "Company")

Change of name

Corporate update

Change of name effective

As previously announced, on 10 January 2018, Shareholders approved at the General Meeting the change of name of the Company to OKYO Pharma Corporation.

The Company announces that the name change has now become effective.

Accordingly, trading in the Company's Ordinary Shares on AIM under the name, OKYO Pharma Corporation, will commence at 8.00 a.m. on 5 February 2018 under a new ISIN, SEDOL and TIDM as set out below:

 
 ISIN    VGG6743A1093 
------  ------------- 
 SEDOL   BF1GCP0 
------  ------------- 
 TIDM    OKYO 
------  ------------- 
 

The change of name will not affect any Shareholders' rights. New issues of Ordinary Share certificates will be in the new name of the Company. Existing Ordinary Share certificates will remain valid and it is not proposed that replacement Ordinary Share certificates be issued in the name of OKYO Pharma Corporation until required.

Further information is available on the Company's website: www.westafricanminerals.com. As from 5 February 2018, the Company's website will be: www.okyopharma.com

Special Dividend

The Disposal of the Company's interest in Ferrum by way of the Special Dividend was also approved at the General Meeting. The Company is currently finalising the arrangements for completion of the Special Dividend and the Board currently anticipates payments of the Special Dividend at the end of this month.

For further information contact:

 
West African Minerals Corporation              Willy Simon        +44 (0)20 7382 8300 
                                               Roland Cornish 
Beaumont Cornish Limited (Nominated Adviser)    Michael Cornish   +44 (0)20 7628 3396 
Beaufort Securities Limited (Broker)           Jon Belliss        +44 (0)20 7382 8300 
 

This announcement is inside information for the purposes of Article 7 of Regulation 596/2014. The person who arranged for the release of this announcement on behalf of the Company was Willy Simon, Director.

Forward-looking statements

Certain statements in this announcement constitute "forward-looking statements". Forward-looking statements include statements concerning the plans, objectives, goals, strategies and future operations and performance of the Company and the assumptions underlying these forward-looking statements. The Company uses the words "anticipates", "estimates", "expects", "believes", "intends", "plans", "may", "will", "should", and any similar expressions to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the Company's actual results, performances or achievements to be materially different from any future results, performances or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company is not obliged, and does not intend, to update or to revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by any applicable law or regulation. All subsequent written or oral forward-looking statements attributable to the Company, or persons acting on behalf of the Company, are expressly qualified in their entirety by the cautionary statements contained throughout this announcement. As a result of these risks, uncertainties and assumptions, a prospective investor should not place undue reliance on these forward-looking statements.

APPENDIX

DEFINITIONS

In this announcement, the following expressions have the following meanings unless the context otherwise requires:

 
 "AIM"                the market of that name operated 
                       by the London Stock Exchange 
 "Disposal"           the proposed disposal of the Ferrum 
                       Shares by means of the Special Dividend 
 "Ferrum"             Ferrum Resources Limited, a wholly-owned 
                       subsidiary of WAFM 
 "Ferrum Shares"      the ordinary shares of no par value 
                       in the capital of Ferrum 
 "General Meeting"    the meeting of the Shareholders 
                       held on 10 January 2018 
 "London Stock        the London Stock Exchange plc 
  Exchange" 
 "Ordinary Shares"    ordinary shares of no par value 
                       in the capital of the Company 
 "Shareholders"       holders of Ordinary Shares 
 "Special Dividend"   the distribution of Ferrum Shares 
                       to Shareholders on the record date 
                       (being the close of business on10 
                       January 2018). 
 "WAFM" or "the       West African Minerals Corporation, 
  Company"             a company incorporated in the British 
                       Virgin Islands with registered number 
                       1415559 
 

ENDS

This information is provided by RNS

The company news service from the London Stock Exchange

END

CANXLLFBVLFFBBX

(END) Dow Jones Newswires

February 02, 2018 08:17 ET (13:17 GMT)

1 Year Okyo Pharma Chart

1 Year Okyo Pharma Chart

1 Month Okyo Pharma Chart

1 Month Okyo Pharma Chart

Your Recent History

Delayed Upgrade Clock